In Parkinson's disease (PD) patients undergoing levodopa (LD) therapy, plasma homocysteine (Hcy) levels are elevated as a result of the transmethylation of LD via catechol O-methyl transferase (COMT) [4, 5]. Here, COMT is linked to Parkinson disease.